Literature DB >> 32244016

Leprosy: Treatment and management of complications.

Mayra B C Maymone1, Samantha Venkatesh2, Melissa Laughter1, Rana Abdat3, Jeremy Hugh1, Mara M Dacso4, P Narasimha Rao5, Barbara M Stryjewska6, Cory A Dunnick1, Robert P Dellavalle7.   

Abstract

In the second article in this continuing medical education series, we review the treatment of leprosy, its immunologic reactions, and important concepts, including disease relapse and drug resistance. A fundamental understanding of the treatment options and management of neuropathic sequelae are essential to reduce disease burden and improve patients' quality of life. Published by Elsevier Inc.

Entities:  

Keywords:  Hansen's disease; Lucio phenomenon; National Hansen's Disease Program; chemoprophylaxis; disease burden; disease relapse; drug resistance; immunoprophylaxis; leprosy; leprosy treatment; prevention; type 1 leprosy reaction; type 2 leprosy reaction

Year:  2020        PMID： 32244016     DOI： 10.1016/j.jaad.2019.10.138

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  7 in total

1.  Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry.

Authors:  Nelson Enrique Arenas; Gilles Pieffet; Cristian Rocha-Roa; Martha Inírida Guerrero
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-18       Impact factor: 2.747

2.  Case Report: A Case Series of Immunobiological Therapy (Anti-TNF-α) for Patients With Erythema Nodosum Leprosum.

Authors:  Ana Flávia Moura Mendes; Ciro Martins Gomes; Patrícia Shu Kurizky; Mayra Ianhez
Journal:  Front Med (Lausanne)       Date:  2022-06-24

Review 3.  Leprosy: clinical and immunopathological characteristics.

Authors:  Luis Alberto Ribeiro Froes; Mirian Nacagami Sotto; Maria Angela Bianconcini Trindade
Journal:  An Bras Dermatol       Date:  2022-04-02       Impact factor: 2.113

Review 4.  Targeting Autophagy as a Strategy for Developing New Vaccines and Host-Directed Therapeutics Against Mycobacteria.

Authors:  Emily J Strong; Sunhee Lee
Journal:  Front Microbiol       Date:  2021-01-14       Impact factor: 6.064

5.  Leprosy Reactions and Neuropathic Pain in Pure Neural Leprosy in a Reference Center in Rio de Janeiro - Brazil.

Authors:  Izabela Jardim Rodrigues Pitta; Mariana Andrea Hacker; Robson Teixeira Vital; Ligia Rocha Andrade; Clarissa Neves Spitz; Anna Maria Sales; Sergio Luiz Gomes Antunes; Euzenir Nunes Sarno; Marcia Rodrigues Jardim
Journal:  Front Med (Lausanne)       Date:  2022-03-25

6.  A Bibliometric Analysis of Leprosy during 2000-2021 from Web of Science Database.

Authors:  Xiang Li; Jing Yang; Lianhua Zhang; Guangjie Jin; Li Xu; Fujin Fang; Yunhui Li; Pingmin Wei
Journal:  Int J Environ Res Public Health       Date:  2022-07-06       Impact factor: 4.614

Review 7.  Systematic Review of Survival Analysis in Leprosy Studies-Including the Following Outcomes: Relapse, Impairment of Nerve Function, Reactions and Physical Disability.

Authors:  Celivane Cavalcanti Barbosa; Gilberto Silva Nunes Bezerra; Amanda Tavares Xavier; Maria de Fátima Pessoa Militão de Albuquerque; Cristine Vieira do Bonfim; Zulma Maria de Medeiros; Wayner Vieira de Souza
Journal:  Int J Environ Res Public Health       Date:  2022-09-26       Impact factor: 4.614
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.